跳至主要内容
临床试验/CTRI/2025/08/092554
CTRI/2025/08/092554尚未招募2/3 期

Open randomized controlled clinical trial of Shalmali Ghrita in Raktapradara with special reference to menorrhagia

Dr Shital Dattrao Budhwant1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2025年8月25日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
68
试验地点
1
主要终点
To evaluate the efficacy of Shalmali Ghrita in management of Raktapradar

研究概览

简要总结

An exhaustive description of gynaecological diseases is mentioned in Ayurveda. The sign and symptom of abnormal excessive vaginal bleeding is given the term Asrugdara. Asrugdara literally means Dirana (excessive release) of Asrik (menstrual blood). Another term Raktapradara is also used which signifies Pradirana (excessive discharge) of Rakta or Rajah (menstrual blood). Aacharya Charaka described Asrugdara as a separate disease along with its management in Yonivyapad Chikitsa Adhyaya.Raktapradar comprises of pradiran which means excessive menstrual blood loss and prolonged menstruation. Cyclic regular menstrual bleeding which is excessive in amount & duration and volume. considered as Menorrhagia. Raktapradar can be correlated with menorrhagia. Abnormal uterine bleeding (AUB) is a broad term that describes irregularities in the menstrual cycle involving frequency, regularity, duration, and volume The treatment protocol for Raktapradar according to Ayurveda is based on correction of pitta dosha anubandhi vata dosha along with Rakta dhatu vata dosha is root cause of all the yoni dushti.Prevalance of Abnormal Uterine Bleeding is 17.09%

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • 1.Women with age group 21 to 40 yrs.
  • 2.Patient having heavy menstruation with prolonged bleeding (more than 7 days) 3.Excessive bleeding for atleast 2 consecutive cycle 4.Patient having regular menstrual cycle 5.Patient having HB more than 7gm %.

排除标准

  • 1.Pregnancy 2.Congenital anamolies of genital tract 3.Patients undergoing treatment for any other illness.
  • 4.Malignancy 5.Bleeding disorders 6.Patient with IUCD or on any other hormonal therapy 7.Systemic causes-uncontrolled hypertension, diabetes 8.Infections like STD 9.Patient with uterine Fibroid of size more than 4cm and more than 3 in number.

结局指标

主要结局

To evaluate the efficacy of Shalmali Ghrita in management of Raktapradar

时间窗: 90 Days

次要结局

  • To review the ayurvedic concept of Raktapradar(To review the concept of)

研究者

发起方
Dr Shital Dattrao Budhwant
申办方类型
Other [Private medical college ]
责任方
Principal Investigator
主要研究者

Dr Shital Dattrao Budhwant

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta

研究点 (1)

Loading locations...

相似试验